$0.83
+0.03 (+3.18%)
Open$0.83
Previous Close$0.81
Day High$0.86
Day Low$0.80
52W High$5.00
52W Low$0.81
Volume—
Avg Volume62.3K
Market Cap4.67M
P/E Ratio—
EPS$-1.36
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+5,151.5% upside
Current
$0.83
$0.83
Target
$43.64
$43.64
$27.68
$43.64 avg
$53.21
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.88M | 2.99M | 1.47M |
| Net Income | -11,146,451 | -7,739,993 | 533.2K |
| Profit Margin | -287.4% | -273.0% | 36.3% |
| EBITDA | -11,164,185 | -8,182,991 | 838.1K |
| Free Cash Flow | — | — | 521.2K |
| Rev Growth | +29.6% | +29.6% | +11.3% |
| Debt/Equity | 0.02 | 0.02 | 0.46 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |